Important news: CFDA may close the drug electronic regulatory network

Source: Cyprian 2016-3-3 state food and Drug Administration held a discussion on the electronic supervision code yesterday The result of the discussion is that the electronic supervision network may be shut down and the enterprise will build its own traceability system On January 25, yangtianhe filed a petition with the first intermediate people's Court of Beijing, suing the State Food and drug administration, saying Ali health lacked legitimacy in promoting electronic supervision codes On the morning of January 27, the State Food and Drug Administration held a symposium on drug electronic supervision in Beijing According to surging news reports, sun Xianze, deputy director general, said at the meeting that the National Bureau would withdraw the operation right of the national drug electronic regulatory network previously handed over to Ali health On February 20, the State Food and Drug Administration issued a notice suspending the implementation of electronic supervision codes by all enterprises and requiring enterprises to establish a traceability system According to the latest news, the National Bureau may shut down the electronic regulatory network, and enterprises will build their own traceability system Whether this discussion can become a reality or not will be announced by the State Administration However, once implemented, it will be a big challenge for both production enterprises and circulation enterprises A big data expert said that it is a high cost way for enterprises to build their own traceability system Referring to food enterprises, taking Li Jinji as an example, they have built a traceability system, which costs at least tens of millions, because providing big data platform needs to provide high technical support, which is not only a heavy burden for the manufacturing industry, but also a relatively heavy burden Big challenge In addition, it is a difficult problem for the industry to build a self built traceability platform and realize traceability throughout the entire supply chain Enterprises must persuade retail terminals, because for retail terminals, this is not only an increase in cost, some retail terminals are not willing to provide such data In reality, pharmaceutical enterprises, circulation enterprises and retail are all equal market entities, which have no compulsory binding force on the downstream "What if the drug companies let them scan the codes and the drugstores don't do it?" Another big data expert said that if every enterprise builds its own traceability platform, it means that changing a manufacturer means changing a scanning device in the circulation link Thousands of pharmaceutical enterprises across the country are adding countless troubles to the circulation link.